| Financial Year |
March 31 2023 |
| Monetary Funds |
1,295,631,952.60 |
| Held-for-trading Financial Assets |
340,820,012.40 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,773,399,882.17 |
| Advances to Suppliers |
3,162,601.29 |
| Other Receivables |
2,484,177.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
742,861,739.08 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,109,909.53 |
| Total Current Assets |
4,794,111,157.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
961,739,431.69 |
| Under-construction Projects |
9,958,346.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
156,587,916.70 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
31,036,004.70 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,166,586,936.95 |
| Total Assets |
5,960,698,094.78 |
| Short-Term Loans |
793,987,421.22 |
| Trading Financial liabilities |
374,243.70 |
| Notes Payable |
1,955,240,000.00 |
| Accounts Payable |
305,772,700.45 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,454,998.09 |
| Taxes Payable |
36,840,736.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
904,258.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,565,404.74 |
| Other Current Liabilities |
896,327.80 |
| Sub-Total of Current Liabilities |
3,110,930,919.91 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,247,787.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
73,738,156.95 |
| Total Liabilities |
3,184,669,076.86 |
| Paid-In Capital(Or Share Stock) |
206,435,681.00 |
| Capital Surplus |
1,589,471,093.01 |
| Surplus Reserve |
103,868,810.72 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
876,253,433.19 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,776,029,017.92 |
| Owner's Equity（Stockholder's Equity） |
2,776,029,017.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,960,698,094.78 |
